Do not chase faster weight loss by undereating Very low intake can contribute to fatigue, weakness, nutrient deficiency, constipation, gallstones and loss of muscle
Glucagon like peptide-1 receptor agonists for the management of obesity and non-alcoholic fatty liver disease: a novel therapeutic option
When artificially raised, however, the brains GLP-1 system powerfully blunts the urge to eat
Healthcare providers consider 12.5 mg the therapeutic sweet spot for most patients pursuing weight loss treatment
Medical Interventions and Over-the-Counter Options If lifestyle changes alone don't resolve constipation after 1-2 weeks, over-the-counter stool softeners like docusate or osmotic laxatives like polyethylene glycol (MiraLAX) are safe first-line options
This dual-action mechanism helps improve insulin sensitivity and reduces food intake